Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Medaxion

Explore full profile

Anesthesia EHR Software: Electronic Health Records | Medaxion

Nashville, United StatesFounded 2008Biotech & Life Sciences
Valuation $100–250M Last recorded · 2023
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Medaxion and the history behind them.

About Medaxion

Medaxion operates in the healthcare technology sector, specializing in anesthesia and pharmacy data management. The company provides a comprehensive Electronic Health Record (EHR) platform designed to optimize Operating Room (OR) performance and revenue. Medaxion serves hospitals and health systems by closing information gaps and identifying lost revenue opportunities. Its core products include Medaxion Pulse, an anesthesia EHR platform, Medaxion Sync, which synchronizes multi-source anesthesia data, and Medaxion Advance Pharmacy, which aggregates point-of-care OR drug data. The business model is based on a subscription service, where clients pay for access to the platform and its analytics capabilities. Medaxion generates revenue through these subscriptions and potentially through additional services such as data analytics and consulting. The market it operates in is the healthcare technology industry, specifically focusing on OR efficiency and data management.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2008
Headquarters
Nashville, United States
Employees
50
Open positions
None listed
Dealroom signal
63.5/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotech & Life Sciences, Testing, Electronic Health Records (EHR), Verification, Biotechnology, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
Client focus
b2c

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Jul 2023 $20M $80M Undisclosed ↗
EARLY VC✓Equity / VC May 2018 $500K $2M Undisclosed —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Medaxion website traffic

Latest recorded traffic for Medaxion is 3K monthly website visits, up 219.1% over the last three months. Medaxion's team declined 3.8% over the past year.

Latest monthly visits3K 3-month web change+219.1% 1-year team growth-3.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Petra Capital Partners

Other known investors1 additional known investor

  • M-One Capital
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Medaxion on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Medaxion’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.